|
 |
| |
| |
|
|
Dr. Lerman is a Mary W. Calkins Professor in both the Department of Psychiatry and the Annenberg School for Communication at the University of Pennsylvania. She is the Associate Director for Cancer Control and Population Science at the Abramson Cancer Center at the University of Pennsylvania. In addition, she is the Director of the University of Pennsylvania Transdisciplinary Tobacco Use Research Center and the Principal Investigator for studies examining the role of genetic factors in response to pharmacotherapy for smoking cessation.
Dr. Lerman's research focuses on the interface between genetics and behavior. For the past decade, she has led several NIH-funded grants to investigate the psychosocial and behavioral impact of genetic testing. More recently, her work has focused on the genetic basis of nicotine dependence.
Dr. Lerman is a member of the National Cancer Institute (NCI) Board of Scientific Advisors and a former member of the National Human Genome Research Institute Advisory Panel on the ELSI (Ethical, Legal, and Social Implications) Program. She has been the recipient of the Society of Behavioral Medicine New Investigator Award (1989), the American Psychological Association Award for Outstanding Contributions to Health Psychology (1995), and the Cullen Award for Tobacco Research from the American Society of Preventive Oncology (2004). Recently, she co-chaired the NCI Tobacco Research Implementation Group that produced recommendations for tobacco research priorities for the next 5-10 years. Dr. Lerman has published more than 200 articles in peer-reviewed journals.
Related Links
CancerNet - Genetics, Causes, Risk Factors, Prevention
Centers for Disease Control - Cancer Prevention and Control |
|
|
|
| |
| TOP |
|
|
| The University of Pennsylvania Health System © 2007, The Trustees of the University of Pennsylvania. Unauthorized reproduction of this material is strictly prohibited.
|
| Disclaimer | Contact Webmaster |
|
|
|
|
